Expanded Access Program of Palopegteriparatide in Patients With Hypoparathyroidism
Clinical trial NCT05654701 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT05654701
- Sponsor
- Ascendis Pharma Bone Diseases A/S
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.